The neutrally charged diarylurea compound PQ401 kills antibiotic-resistant and antibiotic-tolerant Staphylococcus aureus

Resistance or tolerance to traditional antibiotics is a challenging issue in antimicrobial chemotherapy. Moreover, traditional bactericidal antibiotics kill only actively growing bacterial cells, whereas nongrowing metabolically inactive cells are tolerant to and therefore "persist" in the...

Full description

Bibliographic Details
Main Authors: Kim, Wooseong, Zou, Guijin, Pan, Wen, Fricke, Nico, Faizi, Hammad A., Kim, Soo Min, Khader, Rajamohammed, Li, Silei, Lee, Kiho, Escorba, Iliana, Vlahovska, Petia M., Gao, Huajian, Ausubel, Frederick M., Mylonakis, Eleftherios
Other Authors: School of Mechanical and Aerospace Engineering
Format: Journal Article
Language:English
Published: 2021
Subjects:
Online Access:https://hdl.handle.net/10356/146178
_version_ 1811685372555427840
author Kim, Wooseong
Zou, Guijin
Pan, Wen
Fricke, Nico
Faizi, Hammad A.
Kim, Soo Min
Khader, Rajamohammed
Li, Silei
Lee, Kiho
Escorba, Iliana
Vlahovska, Petia M.
Gao, Huajian
Ausubel, Frederick M.
Mylonakis, Eleftherios
author2 School of Mechanical and Aerospace Engineering
author_facet School of Mechanical and Aerospace Engineering
Kim, Wooseong
Zou, Guijin
Pan, Wen
Fricke, Nico
Faizi, Hammad A.
Kim, Soo Min
Khader, Rajamohammed
Li, Silei
Lee, Kiho
Escorba, Iliana
Vlahovska, Petia M.
Gao, Huajian
Ausubel, Frederick M.
Mylonakis, Eleftherios
author_sort Kim, Wooseong
collection NTU
description Resistance or tolerance to traditional antibiotics is a challenging issue in antimicrobial chemotherapy. Moreover, traditional bactericidal antibiotics kill only actively growing bacterial cells, whereas nongrowing metabolically inactive cells are tolerant to and therefore "persist" in the presence of legacy antibiotics. Here, we report that the diarylurea derivative PQ401, previously characterized as an inhibitor of the insulin-like growth factor I receptor, kills both antibiotic-resistant and nongrowing antibiotic-tolerant methicillin-resistant Staphylococcus aureus (MRSA) by lipid bilayer disruption. PQ401 showed several beneficial properties as an antimicrobial lead compound, including rapid killing kinetics, low probability for resistance development, high selectivity to bacterial membranes compared to mammalian membranes, and synergism with gentamicin. In contrast to well-studied membrane-disrupting cationic antimicrobial low-molecular-weight compounds and peptides, molecular dynamic simulations supported by efficacy data demonstrate that the neutral form of PQ401 penetrates and subsequently embeds into bacterial lipid bilayers more effectively than the cationic form. Lastly, PQ401 showed efficacy in both the Caenorhabditis elegans and Galleria mellonella models of MRSA infection. These data suggest that PQ401 may be a lead candidate for repurposing as a membrane-active antimicrobial and has potential for further development as a human antibacterial therapeutic for difficult-to-treat infections caused by both drug-resistant and -tolerant S. aureus.
first_indexed 2024-10-01T04:43:29Z
format Journal Article
id ntu-10356/146178
institution Nanyang Technological University
language English
last_indexed 2024-10-01T04:43:29Z
publishDate 2021
record_format dspace
spelling ntu-10356/1461782023-03-04T17:12:34Z The neutrally charged diarylurea compound PQ401 kills antibiotic-resistant and antibiotic-tolerant Staphylococcus aureus Kim, Wooseong Zou, Guijin Pan, Wen Fricke, Nico Faizi, Hammad A. Kim, Soo Min Khader, Rajamohammed Li, Silei Lee, Kiho Escorba, Iliana Vlahovska, Petia M. Gao, Huajian Ausubel, Frederick M. Mylonakis, Eleftherios School of Mechanical and Aerospace Engineering High Performance Computing Centre, A*STAR Engineering::Mechanical engineering Persisters Antibiotic Tolerance Resistance or tolerance to traditional antibiotics is a challenging issue in antimicrobial chemotherapy. Moreover, traditional bactericidal antibiotics kill only actively growing bacterial cells, whereas nongrowing metabolically inactive cells are tolerant to and therefore "persist" in the presence of legacy antibiotics. Here, we report that the diarylurea derivative PQ401, previously characterized as an inhibitor of the insulin-like growth factor I receptor, kills both antibiotic-resistant and nongrowing antibiotic-tolerant methicillin-resistant Staphylococcus aureus (MRSA) by lipid bilayer disruption. PQ401 showed several beneficial properties as an antimicrobial lead compound, including rapid killing kinetics, low probability for resistance development, high selectivity to bacterial membranes compared to mammalian membranes, and synergism with gentamicin. In contrast to well-studied membrane-disrupting cationic antimicrobial low-molecular-weight compounds and peptides, molecular dynamic simulations supported by efficacy data demonstrate that the neutral form of PQ401 penetrates and subsequently embeds into bacterial lipid bilayers more effectively than the cationic form. Lastly, PQ401 showed efficacy in both the Caenorhabditis elegans and Galleria mellonella models of MRSA infection. These data suggest that PQ401 may be a lead candidate for repurposing as a membrane-active antimicrobial and has potential for further development as a human antibacterial therapeutic for difficult-to-treat infections caused by both drug-resistant and -tolerant S. aureus. Agency for Science, Technology and Research (A*STAR) Nanyang Technological University Published version This study was supported by National Institutes of Health grant P01AI083214 to F.M.A.and E.M. W.K. is supported by the National Research Foundation of Korea grants funded by the South Korean government (MSIT)(2020R1C1C1008842, 2018R1A5A2025286, and 2017M3A9E4077234). G.Z. and H.G. acknowledge support from a start-up grant from the Nanyang Technological University and Institute of High Performance Computing, A*STAR, Singapore. Molecular dynamics simulations reported were performed on resources of the National Supercomputing Centre, Singapore (http://www.nscc.sg). 2021-01-29T03:59:45Z 2021-01-29T03:59:45Z 2020 Journal Article Kim, W., Zou, G., Pan, W., Fricke, N., Faizi, H. A., Kim, S. M., . . . Mylonakis, E. (2020). The neutrally charged diarylurea compound PQ401 kills antibiotic-resistant and antibiotic-tolerant Staphylococcus aureus. mBio, 11(3), e01140-20-. doi:10.1128/mBio.01140-20 2161-2129 https://hdl.handle.net/10356/146178 10.1128/mBio.01140-20 32605985 2-s2.0-85086500393 3 11 en mBio © 2020 Kim et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license. application/pdf
spellingShingle Engineering::Mechanical engineering
Persisters
Antibiotic Tolerance
Kim, Wooseong
Zou, Guijin
Pan, Wen
Fricke, Nico
Faizi, Hammad A.
Kim, Soo Min
Khader, Rajamohammed
Li, Silei
Lee, Kiho
Escorba, Iliana
Vlahovska, Petia M.
Gao, Huajian
Ausubel, Frederick M.
Mylonakis, Eleftherios
The neutrally charged diarylurea compound PQ401 kills antibiotic-resistant and antibiotic-tolerant Staphylococcus aureus
title The neutrally charged diarylurea compound PQ401 kills antibiotic-resistant and antibiotic-tolerant Staphylococcus aureus
title_full The neutrally charged diarylurea compound PQ401 kills antibiotic-resistant and antibiotic-tolerant Staphylococcus aureus
title_fullStr The neutrally charged diarylurea compound PQ401 kills antibiotic-resistant and antibiotic-tolerant Staphylococcus aureus
title_full_unstemmed The neutrally charged diarylurea compound PQ401 kills antibiotic-resistant and antibiotic-tolerant Staphylococcus aureus
title_short The neutrally charged diarylurea compound PQ401 kills antibiotic-resistant and antibiotic-tolerant Staphylococcus aureus
title_sort neutrally charged diarylurea compound pq401 kills antibiotic resistant and antibiotic tolerant staphylococcus aureus
topic Engineering::Mechanical engineering
Persisters
Antibiotic Tolerance
url https://hdl.handle.net/10356/146178
work_keys_str_mv AT kimwooseong theneutrallychargeddiarylureacompoundpq401killsantibioticresistantandantibiotictolerantstaphylococcusaureus
AT zouguijin theneutrallychargeddiarylureacompoundpq401killsantibioticresistantandantibiotictolerantstaphylococcusaureus
AT panwen theneutrallychargeddiarylureacompoundpq401killsantibioticresistantandantibiotictolerantstaphylococcusaureus
AT frickenico theneutrallychargeddiarylureacompoundpq401killsantibioticresistantandantibiotictolerantstaphylococcusaureus
AT faizihammada theneutrallychargeddiarylureacompoundpq401killsantibioticresistantandantibiotictolerantstaphylococcusaureus
AT kimsoomin theneutrallychargeddiarylureacompoundpq401killsantibioticresistantandantibiotictolerantstaphylococcusaureus
AT khaderrajamohammed theneutrallychargeddiarylureacompoundpq401killsantibioticresistantandantibiotictolerantstaphylococcusaureus
AT lisilei theneutrallychargeddiarylureacompoundpq401killsantibioticresistantandantibiotictolerantstaphylococcusaureus
AT leekiho theneutrallychargeddiarylureacompoundpq401killsantibioticresistantandantibiotictolerantstaphylococcusaureus
AT escorbailiana theneutrallychargeddiarylureacompoundpq401killsantibioticresistantandantibiotictolerantstaphylococcusaureus
AT vlahovskapetiam theneutrallychargeddiarylureacompoundpq401killsantibioticresistantandantibiotictolerantstaphylococcusaureus
AT gaohuajian theneutrallychargeddiarylureacompoundpq401killsantibioticresistantandantibiotictolerantstaphylococcusaureus
AT ausubelfrederickm theneutrallychargeddiarylureacompoundpq401killsantibioticresistantandantibiotictolerantstaphylococcusaureus
AT mylonakiseleftherios theneutrallychargeddiarylureacompoundpq401killsantibioticresistantandantibiotictolerantstaphylococcusaureus
AT kimwooseong neutrallychargeddiarylureacompoundpq401killsantibioticresistantandantibiotictolerantstaphylococcusaureus
AT zouguijin neutrallychargeddiarylureacompoundpq401killsantibioticresistantandantibiotictolerantstaphylococcusaureus
AT panwen neutrallychargeddiarylureacompoundpq401killsantibioticresistantandantibiotictolerantstaphylococcusaureus
AT frickenico neutrallychargeddiarylureacompoundpq401killsantibioticresistantandantibiotictolerantstaphylococcusaureus
AT faizihammada neutrallychargeddiarylureacompoundpq401killsantibioticresistantandantibiotictolerantstaphylococcusaureus
AT kimsoomin neutrallychargeddiarylureacompoundpq401killsantibioticresistantandantibiotictolerantstaphylococcusaureus
AT khaderrajamohammed neutrallychargeddiarylureacompoundpq401killsantibioticresistantandantibiotictolerantstaphylococcusaureus
AT lisilei neutrallychargeddiarylureacompoundpq401killsantibioticresistantandantibiotictolerantstaphylococcusaureus
AT leekiho neutrallychargeddiarylureacompoundpq401killsantibioticresistantandantibiotictolerantstaphylococcusaureus
AT escorbailiana neutrallychargeddiarylureacompoundpq401killsantibioticresistantandantibiotictolerantstaphylococcusaureus
AT vlahovskapetiam neutrallychargeddiarylureacompoundpq401killsantibioticresistantandantibiotictolerantstaphylococcusaureus
AT gaohuajian neutrallychargeddiarylureacompoundpq401killsantibioticresistantandantibiotictolerantstaphylococcusaureus
AT ausubelfrederickm neutrallychargeddiarylureacompoundpq401killsantibioticresistantandantibiotictolerantstaphylococcusaureus
AT mylonakiseleftherios neutrallychargeddiarylureacompoundpq401killsantibioticresistantandantibiotictolerantstaphylococcusaureus